Cited by 1,793Tuberous Sclerosis Complex ResearchGenetic and rare skin diseases.PI3K/AKT/mTOR signaling in cancer

The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.

The Tuberous Sclerosis Complex

Crino, Peter B., Nathanson, Katherine L., Henske, Elizabeth Petri·2006·New England Journal of Medicine

Open this paper in CoChat — free account

Abstract

The tuberous sclerosis complex (TSC), a multisystem, autosomal dominant disorder affecting children and adults, results from mutations in one of two genes, TSC1 (encoding hamartin) or TSC2 (encoding tuberin). In this article, the current knowledge of the pathogenesis of the disease and its management are discussed.

Integrity signals

Registry

Crossref · 10.1056/nejmra055323

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Phosphatidylinositol 3-Kinase/Akt Pathway Regulates Tuberous Sclerosis Tumor Suppressor Complex by Phosphorylation of Tuberin
Dan, H. C., Sun, M., Yang, L., Feldman, R. I., Sui, X.-M., Ou, C. C., Nellist, M. D., Yeung, R. S. W., Halley, D. J. J., Nicosia, S. V., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205838200 · Cited by 370
Retracted
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
Inoki, K., Li, Y., Xu, T., & Guan, K.-L. (2003) · Genes & Development · doi:10.1101/gad.1110003 · Cited by 1,911
Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34
Slegtenhorst, M. V., Hoogt, R. D., Hermans, C., Nellist, M., Janssen, B., Verhoef, S., Lindhout, D., Ouweland, A. V. D., Halley, D., Young, J., et al. (1997) · Science · doi:10.1126/science.277.5327.805 · Cited by 1,648
Self-citation
Identification and characterization of the tuberous sclerosis gene on chromosome 16
(1993) · Cell · doi:10.1016/0092-8674(93)90618-z · Cited by 1,645
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway
Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555
Phosphorylation and Functional Inactivation of TSC2 by Erk
Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P., & Pandolfi, P. P. (2005) · Cell · doi:10.1016/j.cell.2005.02.031 · Cited by 1,268
Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression
Fingar, D. C., & Blenis, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207542 · Cited by 1,264
The LKB1 tumor suppressor negatively regulates mTOR signaling
Shaw, R. J., Bardeesy, N. M., Manning, B. D., Lopez, L. V., Kosmatka, M., DePinho, R. A., & Cantley, L. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.007 · Cited by 1,107

Show all 98 references

Research works printed but not linked: 7

Bourneville DM, 1880, Arch Neurol (Paris), 1, 81
Bjornsson J, 1996, Am J Pathol, 149, 1201
Henske EP, 1996, Am J Hum Genet, 59, 400
Plank TL, 1998, Cancer Res, 58, 4766
Plank TL, 1999, Mod Pathol, 12, 539
Wienecke R, 1996, Oncogene, 13, 913
Liu MY, 2002, Cancer Res, 62, 6475

Sorted by citations

Items 501–600 of 1,001

PI3K Signaling in Tissue Hyper-Proliferation: From Overgrowth Syndromes to Kidney Cysts
Santis, M. C. D., Sala, V., Martini, M., Ferrero, G. B., & Hirsch, E. (2017) · Cancers · doi:10.3390/cancers9040030 · Cited by 41
Tuberous sclerosis‐associated neuropsychiatric disorders: a paediatric cohort study
Toldo, I., Brasson, V., Miscioscia, M., Pelizza, M. F., Manara, R., Sartori, S., Mantegazza, G., Vecchi, M., Nosadini, M., & Gatta, M. (2018) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14055 · Cited by 41
Inherited syndromes involving pancreatic neuroendocrine tumors
Geurts, J. L. (2020) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2020.03.09 · Cited by 41
Region Specific Brain Organoids to Study Neurodevelopmental Disorders
Susaimanickam, P. J., Kiral, F. R., & Park, I. (2022) · International Journal of Stem Cells · doi:10.15283/ijsc22006 · Cited by 47
Animal models
(2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52898-8.00004-5 · Cited by 40
A Novel Covalent mTOR Inhibitor, DHM25, Shows in Vivo Antitumor Activity against Triple-Negative Breast Cancer Cells
Fouqué, A., Delalande, O., Jean, M., Castellano, R., Josselin, E., Malleter, M., Shoji, K. F., Mac, D. H., Rampanarivo, H., Collette, Y., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00991 · Cited by 40
Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors
Asa, S. L., Rosa, S. L., Baştürk, O., Adsay, V. N., Minnetti, M., & Grossman, A. B. (2021) · Endocrine Pathology · doi:10.1007/s12022-021-09662-5 · Cited by 41
A management strategy for intraventricular subependymal giant cell astrocytomas in tuberous sclerosis complex
Harter, D. H., Bassani, L., Rodgers, S. D., Roth, J., Devinsky, O., Carlson, C., Wisoff, J. H., & Weiner, H. L. (2013) · Journal of Neurosurgery Pediatrics · doi:10.3171/2013.9.peds13193 · Cited by 40
Efficacy and Safety of Sirolimus for Renal Angiomyolipoma in Patients with Tuberous Sclerosis Complex or Sporadic Lymphangioleiomyomatosis: A Systematic Review
Peng, Z., Yang, L., Wang, T., Han, P., Liu, Z., & Wei, Q. (2014) · The Journal of Urology · doi:10.1016/j.juro.2014.04.096 · Cited by 39
Developing Antiepileptogenic Drugs for Acquired Epilepsy: Targeting the Mammalian Target of Rapamycin (mTOR) Pathway
Zeng, L. (2009) · Molecular and Cellular Pharmacology · doi:10.4255/mcpharmacol.09.16 · Cited by 39
Spectrum of Preneoplastic and Neoplastic Cystic Lesions of the Kidney
Chen, Y., & Tickoo, S. K. (2012) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2011-0485-ra · Cited by 39
Using genetics and genomics strategies to personalize therapy for cancer: Focus on melanoma
Nathanson, K. L. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.04.017 · Cited by 39
Self-citation
The E3 Ubiquitin Ligase Protein Associated with Myc (Pam) Regulates Mammalian/Mechanistic Target of Rapamycin Complex 1 (mTORC1) Signaling in Vivo through N- and C-terminal Domains
Han, S., Kim, S. Y., Bahl, S., Li, L., Burande, C. F., Smith, N., James, M. F., Beauchamp, R. L., Bhide, P. G., DiAntonio, A., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.353987 · Cited by 39
Structure of the TBC1D7–TSC1 complex reveals that TBC1D7 stabilizes dimerization of the TSC1 C-terminal coiled coil region
Gai, Z., Chu, W., Deng, W., Li, W., Li, H. L., He, A., Nellist, M. D., & Wu, G. (2016) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjw001 · Cited by 41
Excitatory/Inhibitory Synaptic Ratios in Polymicrogyria and Down Syndrome Help Explain Epileptogenesis in Malformations
Sarnat, H. B., & Flores‐Sarnat, L. (2020) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2020.11.001 · Cited by 42
Precision Therapy for Epilepsy Related to Brain Malformations
D’Gama, A. M., & Poduri, A. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01122-6 · Cited by 40
Brain-enriched RagB isoforms regulate the dynamics of mTORC1 activity through GATOR1 inhibition
Figlia, G., Müller, S., Hagenston, A. M., Kleber, S., Roiuk, M., Quast, J.-P., ten Bosch, N., Ibañez, D. C., Mauceri, D., Martín-Villalba, A., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00977-x · Cited by 41
Clinical practice recommendations for kidney involvement in tuberous sclerosis complex: a consensus statement by the ERKNet Working Group for Autosomal Dominant Structural Kidney Disorders and the ERA Genes & Kidney Working Group
Mekahli, D., Müller, R., Marlais, M., Wlodkowski, T., Haeberle, S., López-Argumedo, M., Bergmann, C., Breysem, L., Fladrowski, C., Henske, E. P., et al. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00818-0 · Cited by 42
Self-citation
Rheb signaling and tumorigenesis: mTORC1 and new horizons
Armijo, M. E., Campos, T., Fuentes‐Villalobos, F., Palma, M., Pincheira, R., & Castro, A. F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29707 · Cited by 38
Long-Term Everolimus Treatment in Individuals With Tuberous Sclerosis Complex: A Review of the Current Literature
Tran, L. H., & Zupanc, M. L. (2014) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2014.10.024 · Cited by 38
Clinically Relevant Imaging in Tuberous Sclerosis
Radhakrishnan, R., & Verma, S. (2011) · Journal of Clinical Imaging Science · doi:10.4103/2156-7514.83230 · Cited by 38
Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis?
Neurohr, C., Hoffmann, A. L., Huppmann, P., Herrera, V. A., Ihle, F., Leuschner, S., von Wulffen, W., Meis, T., Baezner, C. J., Leuchte, H. H., et al. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-66 · Cited by 38
Mammalian target of rapamycin signaling in the podocyte
Inoki, K., & Huber, T. B. (2012) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283520f38 · Cited by 38
Everolimus improves neuropsychiatric symptoms in a patient with tuberous sclerosis carrying a novel TSC2 mutation
Hwang, S., Lee, J., Yang, J.-E., Lim, C., Lee, J., Lee, Y., Lee, K., & Kaang, B. (2016) · Molecular Brain · doi:10.1186/s13041-016-0222-6 · Cited by 40
Laser interstitial thermal therapy for subependymal giant cell astrocytoma: technical case report
Dadey, D. Y. A., Kamath, A. A., Leuthardt, E. C., & Smyth, M. D. (2016) · Neurosurgical FOCUS · doi:10.3171/2016.7.focus16231 · Cited by 38
Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition
Mateo, F., Arenas, E. J., Aguilar, H., Serra-Musach, J., de Garibay, G. R., Boni, J., Maicas, M., Du, S., Iorio, F., Herranz, C., et al. (2016) · Oncogene · doi:10.1038/onc.2016.427 · Cited by 37
Inherited kidney cancer syndromes
Ball, M. W., & Shuch, B. M. (2019) · Current Opinion in Urology · doi:10.1097/mou.0000000000000646 · Cited by 38
Lymphangioleiomyomatosis and Tuberous Sclerosis Complex
Chorianopoulos, D., & Stratakos, G. K. (2008) · Lung · doi:10.1007/s00408-008-9087-5 · Cited by 38
Regression of massive cardiac rhabdomyoma on everolimus therapy
Hoshal, S. G., Samuel, B. P., Schneider, J. R., Mammen, L., & Vettukattil, J. J. (2015) · Pediatrics International · doi:10.1111/ped.12816 · Cited by 38
Solid renal masses in adults
Mittal, M. K., & Sureka, B. (2016) · Indian journal of radiology and imaging - new series/Indian journal of radiology and imaging/Indian Journal of Radiology & Imaging · doi:10.4103/0971-3026.195773 · Cited by 38
Structural Basis of the Interaction between Tuberous Sclerosis Complex 1 (TSC1) and Tre2-Bub2-Cdc16 Domain Family Member 7 (TBC1D7)
Qin, J., Wang, Z., Hoogeveen-Westerveld, M., Shen, G., Gong, W., Nellist, M., & Xu, W. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.701870 · Cited by 37
mTORC1 enhancement of STIM1-mediated store-operated Ca2+ entry constrains tuberous sclerosis complex-related tumor development
Peng, H., Liu, J., Sun, Q., Chen, R., Wang, Y., Duan, J., Li, C., Li, Z., Jing, Y., Chen, X.-T., et al. (2012) · Oncogene · doi:10.1038/onc.2012.481 · Cited by 37
Therapeutic Targeting of Cellular Metabolism in Cells with Hyperactive mTORC1: A Paradigm Shift
Medvetz, D. A., Priolo, C., & Henske, E. P. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0343 · Cited by 37
Self-citation
A Phase II Clinical Trial of an Aromatase Inhibitor for Postmenopausal Women with Lymphangioleiomyomatosis
Lu, C., Lee, H. S., Pappas, G. P., Dilling, D. F., Burger, C. D., Shifren, A., Veeraraghavan, S., Chapman, J. T., Parambil, J. G., Ruoss, S. J., et al. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201610-824oc · Cited by 38
Uncoupling of ER/Mitochondrial Oxidative Stress in mTORC1 Hyperactivation-Associated Skin Hypopigmentation
Yang, F., Yang, L., Wataya‐Kaneda, M., Yoshimura, T., Tanemura, A., & Katayama, I. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.10.007 · Cited by 38
Intracranial calcifications in childhood: Part 1
Gonçalves, F. G., Caschera, L., Teixeira, S. R., Viaene, A. N., Pinelli, L., Mankad, K., Alves, C., Ortiz-Gonzalez, X. R., Andronikou, S., & Vossough, A. (2020) · Pediatric Radiology · doi:10.1007/s00247-020-04721-1 · Cited by 37
A High-Throughput, Cell-Based Screening Method for siRNA and Small Molecule Inhibitors of mTORC1 Signaling Using the In Cell Western Technique
Hoffman, G. R., Moerke, N. J., Hsia, M., Shamu, C. E., & Blenis, J. (2010) · Assay and Drug Development Technologies · doi:10.1089/adt.2009.0213 · Cited by 37
Imaging of tuberous sclerosis complex: a pictorial review
von Ranke, F. M., Faria, I. M., Zanetti, G. M. R., a, B. H., Souza, A. S., & Marchiori, E. D. S. (2017) · Radiologia Brasileira · doi:10.1590/0100-3984.2016.0020 · Cited by 37
Identification of a region required for TSC1 stability by functional analysis of TSC1missense mutations found in individuals with tuberous sclerosis complex
Mozaffari, M., Hoogeveen-Westerveld, M., Kwiatkowski, D., Sampson, J., Ekong, R., Povey, S., den Dunnen, J. T., van den Ouweland, A., Halley, D., & Nellist, M. (2009) · BMC Medical Genetics · doi:10.1186/1471-2350-10-88 · Cited by 36
Recommendations for the radiological diagnosis and follow-up of neuropathological abnormalities associated with tuberous sclerosis complex
Rovira, À., Ruiz-Falcó, M. L., Esparza, E. G., López‐Laso, E., Macaya, A., Málaga, I., Méndez, E. V., & Vicente, J. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1429-y · Cited by 36
Management of epilepsy in tuberous sclerosis complex
Curatolo, P., D'Argenzio, L., Cerminara, C., & Bombardieri, R. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.3.457 · Cited by 39
Brain Tumors: Epidemiology and Current Trends in Treatment
Strong, M. J., & Garces, J. (2016) · Journal of Brain Tumors & Neurooncology · doi:10.4172/2475-3203.1000102 · Cited by 44
Clear Cell Papillary Renal Cell Carcinoma
Zhao, J., & Eyzaguirre, E. J. (2019) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2018-0121-rs · Cited by 36
New frontiers in modeling tuberous sclerosis with human stem cell‐derived neurons and brain organoids
Blair, J. D., & Bateup, H. S. (2019) · Developmental Dynamics · doi:10.1002/dvdy.60 · Cited by 37
Neuroligin 3 Regulates Dendritic Outgrowth by Modulating Akt/mTOR Signaling
Xu, J., Du, Y.-L., Xu, J.-W., Hu, X., Gu, L.-F., Li, X., Hu, P.-H., Liao, T., Xia, Q.-Q., Sun, Q., et al. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00518 · Cited by 35
Genotype and Phenotype Analysis of Chinese Children With Tuberous Sclerosis Complex: A Pediatric Cohort Study
Ding, Y., Wang, J., Zhou, S., Zhou, Y., Zhang, L., Yu, L., & Wang, Y. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00204 · Cited by 36
Bilateral invasive electroencephalography in patients with tuberous sclerosis complex: a path to surgery?
Carlson, C., Teutonico, F., Elliott, R. E., Moshel, Y. A., LaJoie, J., Miles, D. K., Devinsky, O., & Weiner, H. L. (2011) · Journal of Neurosurgery Pediatrics · doi:10.3171/2011.1.peds10348 · Cited by 36
Tuberous Sclerosis Complex 2 Loss Increases Lysophosphatidylcholine Synthesis in Lymphangioleiomyomatosis
Priolo, C., Ricoult, S. J. H., Khabibullin, D., Filippakis, H., Yu, J. J., Manning, B. D., Clish, C. B., & Henske, E. P. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0379rc · Cited by 33
Self-citation
Rheb activation disrupts spine synapse formation through accumulation of syntenin in tuberous sclerosis complex
Sugiura, H., Yasuda, S., Katsurabayashi, S., Kawano, H., Endo, K., Takasaki, K., Iwasaki, K., Ichikawa, M., Kobayashi, T., Hino, O., et al. (2015) · Nature Communications · doi:10.1038/ncomms7842 · Cited by 37
Optimal management of seizures associated with tuberous sclerosis complex: current and emerging options
Fallah, A., & Wang, S. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s51789 · Cited by 36
mTOR-related neuropathology in mutant tsc2 zebrafish: Phenotypic, transcriptomic and pharmacological analysis
Scheldeman, C., Mills, J. D., Siekierska, A., Serra, I., Copmans, D., Iyer, A. M., Whalley, B. J., Maes, J., Jansen, A., Lagae, L. G., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.09.004 · Cited by 36
RUNX1/EGFR pathway contributes to STAT3 activation and tumor growth caused by hyperactivated mTORC1
Lin, W., Wan, X., Sun, A., Zhou, M., Chen, X., Li, Y., Wang, Z., Huang, H., Li, H., Chen, X., et al. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.10.009 · Cited by 36
A pilot study in epilepsy patients using simultaneous PET/MR.
Ding, Y., Chen, B., Glielmi, C. B., Friedman, K. P., & Devinsky, O. (2014) · Europe PMC (PubMed Central) · Cited by 35
Effects of Combining Rapamycin and Resveratrol on Apoptosis and Growth of TSC2-Deficient Xenograft Tumors
Alayev, A., Salamon, R. S., Sun, Y., Schwartz, N. S., Li, C., Yu, J. J., & Holz, M. K. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0022oc · Cited by 35
Rapamycin down-regulates KCC2 expression and increases seizure susceptibility to convulsants in immature rats
Huang, X., McMahon, J. J., Yang, J., Shin, D., & Huang, Y. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.003 · Cited by 35
Assisting a child with tuberous sclerosis complex (TSC): a qualitative deep analysis of parents’ experience and caring needs
Graffigna, G., Bosio, C., & Cecchini, I. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003707 · Cited by 35
Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis
Glasgow, C. G., El‐Chemaly, S., & Moss, J. (2012) · European Respiratory Review · doi:10.1183/09059180.00009311 · Cited by 34
Spatial regulation of the mTORC1 system in amino acids sensing pathway
Suzuki, T., & Inoki, K. (2011) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmr066 · Cited by 36
Corticostriatal Transmission Is Selectively Enhanced in Striatonigral Neurons with Postnatal Loss of Tsc1
Benthall, K. N., Ong, S. L., & Bateup, H. S. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.037 · Cited by 32
Finding a cure for tuberous sclerosis complex: From genetics through to targeted drug therapies
McEneaney, L. J., & Tee, A. R. (2018) · Advances in genetics · doi:10.1016/bs.adgen.2018.11.003 · Cited by 36
Targeting the mTOR regulatory network in hepatocellular carcinoma: Are we making headway?
Yu, X., Chen, H., Liu, T., Wu, J. H., Zhu, J., & Shen, X. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.03.001 · Cited by 34
At the bottom of the differential diagnosis list: unusual causes of pediatric hypertension
Grinsell, M. M., & Norwood, V. F. (2008) · Pediatric Nephrology · doi:10.1007/s00467-008-0744-y · Cited by 35
Managing and understanding epilepsy in tuberous sclerosis complex
Thiele, E. A. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02458.x · Cited by 35
Tuberous sclerosis complex-associated kidney angiomyolipoma: from contemplation to action
Pirson, Y. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft009 · Cited by 35
Effectiveness and safety of everolimus treatment in patients with tuberous sclerosis complex in real-world clinical practice
Cockerell, I., Christensen, J., Hoei‐Hansen, C. E., Holst, L., Frederiksen, M. G., Issa-Epe, A. I., Nedregaard, B., Solhoff, R., Heimdal, K., Landmark, C. J., et al. (2023) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-023-02982-1 · Cited by 35
Genetics and Pharmacology of Longevity
Castillo-Quan, J. I., Kinghorn, K. J., & Bjedov, I. (2015) · Advances in genetics · doi:10.1016/bs.adgen.2015.06.002 · Cited by 37
Efficacy of combined inhibition of mTOR and ERK/MAPK pathways in treating a tuberous sclerosis complex cell model
Mi, R., Ma, J., Zhang, D., Li, L., & Zhang, H. (2009) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/s1673-8527(08)60124-1 · Cited by 34
Associations between electroencephalographic and magnetic resonance imaging findings in tuberous sclerosis complex
Gallagher, A., Chu, C. J., Montenegro, M. A., Major, P., Costello, D. J., Lyczkowski, D. A., Muzykewicz, D. A., Doherty, C. P., & Thiele, E. A. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2009.09.001 · Cited by 34
Treatment of renal angiomyolipoma in tuberous sclerosis complex (TSC) patients
Brakemeier, S., Bachmann, F., & Budde, K. (2016) · Pediatric Nephrology · doi:10.1007/s00467-016-3474-6 · Cited by 34
FCD Type II and mTOR pathway: Evidence for different mechanisms involved in the pathogenesis of dysmorphic neurons
Rossini, L., Villani, F. S., Granata, T., Tassi, L., Tringali, G., Cardinale, F., Aronica, E., Spreafico, R., & Garbelli, R. (2016) · Epilepsy Research · doi:10.1016/j.eplepsyres.2016.12.002 · Cited by 34
Treatment of Renal Angiomyolipoma and Other Hamartomas in Patients with Tuberous Sclerosis Complex
Samuels, J. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08150816 · Cited by 35
Hyperexcitability of the local cortical circuit in mouse models of tuberous sclerosis complex
Zhao, J.-P., & Yoshii, A. (2019) · Molecular Brain · doi:10.1186/s13041-019-0427-6 · Cited by 34
Chemical Phosphoproteomics Sheds New Light on the Targets and Modes of Action of AKT Inhibitors
Wiechmann, S., Ruprecht, B., Siekmann, T., Zheng, R., Frejno, M., Kunold, E., Bajaj, T., Zolg, D. P., Sieber, S. A., Gassen, N. C., et al. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.0c00872 · Cited by 34
Cystogenesis and elongated primary cilia in Tsc1-deficient distal convoluted tubules
Armour, E. A., Carson, R. P., & Ess, K. C. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00141.2012 · Cited by 36
Hyponatremia Associated with Escitalopram
Covyeou, J. A., & Jackson, C. W. (2007) · New England Journal of Medicine · doi:10.1056/nejmc062840 · Cited by 34
A hypomorphic allele of Tsc2 highlights the role of TSC1/TSC2 in signaling to AKT and models mild human TSC2 alleles
Pollizzi, K. N., Malinowska-Kołodziej, I., Doughty, C. A., Betz, C., Ma, J., Goto, J., & Kwiatkowski, D. J. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp176 · Cited by 34
Tumor growth in patients with tuberous sclerosis complex on the ketogenic diet
Chu, C. J., & Thiele, E. A. (2009) · Brain and Development · doi:10.1016/j.braindev.2009.04.009 · Cited by 34
Developmentally arrested structures preceding cerebellar tumors in von Hippel–Lindau disease
Shively, S. B., Falke, E., Li, J., Tran, M. G. B., Thompson, E. R., Maxwell, P. H., Roessler, E., Oldfield, E. H., Lonser, R. R., & Vortmeyer, A. O. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.61 · Cited by 34
Emerging biomarkers of lymphangioleiomyomatosis
Nijmeh, J., El‐Chemaly, S., & Henske, E. P. (2017) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2018.1409622 · Cited by 34
Self-citation
Tsc1 is a Critical Regulator of Macrophage Survival and Function
Fang, C., Yu, J., Luo, Y., Chen, S., Wang, W., Zhao, C., Sun, Z., Wu, W., Guo, W., Han, Z., et al. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430306 · Cited by 33
Successful everolimus therapy for SEGA in pediatric patients with tuberous sclerosis complex
Cappellano, A. M., Senerchia, A. A., Adolfo, F., Paiva, P. M., Pinho, R. S., Covic, A. N., Cavalheiro, S., & Saba, N. (2013) · Child s Nervous System · doi:10.1007/s00381-013-2170-0 · Cited by 33
Fission yeast Any1, β-arrestin-like protein, is involved in TSC-Rheb signaling and the regulation of amino acid transporters
Nakase, Y., Nakase, M., Kashiwazaki, J., Murai, T., Otsubo, Y., Mabuchi, I., Yamamoto, M. P., Takegawa, K., & Matsumoto, T. (2013) · Journal of Cell Science · doi:10.1242/jcs.128355 · Cited by 33
Thyroid transcription factor-1 distinguishes subependymal giant cell astrocytoma from its mimics and supports its cell origin from the progenitor cells in the medial ganglionic eminence
Hang, J., Hsu, C., Lin, S., Wu, C., Lee, H.-J., & Ho, D. M. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.205 · Cited by 34
Englerin A induces an acute inflammatory response and reveals lipid metabolism and ER stress as targetable vulnerabilities in renal cell carcinoma
Batova, A., Altomare, D., Creek, K. E., Naviaux, R. K., Wang, L., Li, K., Green, E., Williams, R. T., Naviaux, J. C., Diccianni, M. B., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172632 · Cited by 33
mTOR and epileptogenesis in developmental brain malformations
Wong, M., & Crino, P. B. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02858.x · Cited by 32
Self-citation
mTORC signaling in hematopoiesis
Wang, X., Chu, Y., Wang, W., & Yuan, W. (2016) · International Journal of Hematology · doi:10.1007/s12185-016-1944-z · Cited by 32
Everolimus in pregnancy: Case report and literature review
Yamamura, M., Kojima, T., Koyama, M., Sazawa, A., Yamada, T., & Minakami, H. (2017) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13369 · Cited by 32
Metformin use and its effect on gastric cancer in patients with type 2 diabetes: A systematic review of observational studies
Li, P., Zhang, C., Gao, P., Chen, X., Ma, B., Yu, D., Song, Y., & Wang, Z. (2017) · Oncology Letters · doi:10.3892/ol.2017.7370 · Cited by 32
Recent advances in human stem cell-based modeling of Tuberous Sclerosis Complex
Saber, W. A., & Şahin, M. (2020) · Molecular Autism · doi:10.1186/s13229-020-0320-2 · Cited by 30
Natural clusters of tuberous sclerosis complex (TSC)-associated neuropsychiatric disorders (TAND): new findings from the TOSCA TAND research project
de Vries, P. J., Belousova, E., Benedik, M. P., Carter, T., Cottin, V., Curatolo, P., D’Amato, L., d’Augères, G. B., Ferreira, J. C., Feucht, M., et al. (2020) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-020-09327-0 · Cited by 33
Tuberous sclerosis complex: a brave new world?
Ess, K. C. (2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32832c4ff5 · Cited by 33
Recent Advances in Renal Tumors with TSC/mTOR Pathway Abnormalities in Patients with Tuberous Sclerosis Complex and in the Sporadic Setting
Kapur, P., Brugarolas, J., & Trpkov, K. (2023) · Cancers · doi:10.3390/cancers15164043 · Cited by 32
Research and innovation in the development of everolimus for oncology
Lebwohl, D., Thomas, G., Lane, H. A., O’Reilly, T., Escudier, B. J., Yao, J. C., Pavel, M., Franz, D. N., Berg, W. J., Baladi, J., et al. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.558079 · Cited by 31
High-Throughput Drug Screen Identifies Chelerythrine as a Selective Inducer of Death in a TSC2-null Setting
Medvetz, D. A., Sun, Y., Li, C., Khabibullin, D., Balan, M., Parkhitko, A. A., Priolo, C., Asara, J. M., Pal, S., Yu, J. J., et al. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0440 · Cited by 30
Self-citation
Long-term Clinical Morbidity in Patients With Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex
Bissler, J. J., Cappell, K. A., Charles, H. W., Song, X., Liu, Z., Prestifilippo, J., Gregory, C. W., & Hulbert, J. C. (2016) · Urology · doi:10.1016/j.urology.2016.04.027 · Cited by 31
Overlapping Molecular Pathways Leading to Autism Spectrum Disorders, Fragile X Syndrome, and Targeted Treatments
Salcedo‐Arellano, M. J., Cabal-Herrera, A. M., Punatar, R., Clark, C. J., Romney, C. A., & Hagerman, R. J. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00968-6 · Cited by 32
Zebrafish Cancer Predisposition Models
Kobar, K., Collett, K., Prykhozhij, S. V., & Berman, J. N. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.660069 · Cited by 34
Inhibition of Mammalian Target of Rapamycin Signaling by 2-(Morpholin-1-yl)pyrimido[2,1-α]isoquinolin-4-one
Ballou, L. M., Selinger, E. S., Choi, J. Y., Drueckhammer, D. G., & Lin, R. Z. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704741200 · Cited by 31
Congenital subependymal giant cell astrocytoma: clinical considerations and expression of radial glial cell markers in giant cells
Phi, J. H., Park, S., Chae, J., Hong, K. H., Park, S. S., Kang, J. H., Jun, J. K., Cho, B.-K., Wang, K., & Kim, S. (2008) · Child s Nervous System · doi:10.1007/s00381-008-0681-x · Cited by 31
Frequency of Undiagnosed Cystic Lung Disease in Patients With Sporadic Renal Angiomyolipomas
Ryu, J. H., Hartman, T. E., Torres, V. E., & Decker, P. A. (2011) · CHEST Journal · doi:10.1378/chest.11-0669 · Cited by 31

Authors: Crino, P. B., Nathanson, K. L., & Henske, E. P.
Affiliations: University of Pennsylvania Health System (US)
University of Pennsylvania (US)
Fox Chase Cancer Center (US)
ORCID: Crino, Peter B.
Nathanson, Katherine L.
Henske, Elizabeth Petri
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2006-09-28
Volume: 355
Issue: 13
Pages: 1345-1356
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra055323
OpenAlex: W2383259826
Cited by: 1,793
References: 98
Citations by year: 2026: 39 · 2025: 61 · 2024: 73 · 2023: 61 · 2022: 79 · 2021: 96 · 2020: 94 · 2019: 67 · 2018: 95 · 2017: 101 · 2016: 102 · 2015: 109 · 2014: 119 · 2013: 146 · 2012: 129
FWCI: 7.94
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (HL60746, R01HL060746)
National Institute of Diabetes and Digestive and Kidney Diseases (DK-51052)
National Institute of Neurological Disorders and Stroke (NS045021, R01NS045021)
Topics: Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
Health Sciences › Medicine › Dermatology › Genetic and rare skin diseases.
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords: tuberous sclerosis complex, TSC1, hamartin, TSC2, tuberin, autosomal dominant disorder, pathogenesis, disease management, multisystem disease
MeSH terms: Tuberous Sclerosis Complex 1 Protein, Tuberous Sclerosis Complex 2 Protein, Estrogens, Female, Humans, Genetic Linkage, Male, Mutation, Protein Kinases, Tuberous Sclerosis, Signal Transduction, Tumor Suppressor Proteins, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Tuberous Sclerosis Complex

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks